Drug Topics
OCTOBER 16, 2024
Posters presented at ACCP 2024 revealed gaps in pharmacy students’ understanding of off-label drug applications and identified strengths and weaknesses among pharmacy graduates.
PharmaVoice
OCTOBER 16, 2024
Even drugs with “blockbuster potential” often fall short of expectations. Here’s what can help a new medication pass the $1 billion mark.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
OCTOBER 16, 2024
Pharmacist-led medication therapy management can help reduce costs associated with diabetes management.
STAT
OCTOBER 16, 2024
If you’re aware of the H5N1 bird flu outbreak in U.S. dairy cattle — you may have seen some headlines or read something on social media — perhaps you are wondering what the fuss is about. Yes, there have been nearly a couple dozen human cases, but all have had mild symptoms. The virus does not decimate herds in the way it does poultry flocks; most — though not all — of the infected cows come through the illness OK.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
OCTOBER 16, 2024
Gepotidacin is a first-in-class oral antibiotic with a novel mechanism of action.
STAT
OCTOBER 16, 2024
The emails from UnitedHealth Group managers were filled with exclamation marks and pleasantries about the weather. But the underlying message to doctors in late 2020 was persistent and urgent: Hit your targets to see more patients. We need to bring in more money. At the time, deaths from Covid-19 were surging, and no vaccine was available.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
The Guardian - Pharmaceutical Industry
OCTOBER 16, 2024
Novo Nordisk’s decision will force people in developing countries to use outdated glass vials and syringes, warn campaigners The pharmaceutical company behind injectable weight-loss drugs has been accused of prioritising profits over the health of people in developing countries by halting production of its insulin pens. People living with type 1 diabetes who are reliant on the human insulin produced by Novo Nordisk, will instead be given glass vials and syringes – which they say are inconvenient
Drug Topics
OCTOBER 16, 2024
In an installment of Drug Topics’ 5 Questions With a Pharmacist, Stevie Veach of MercyOne Pharmacy in Dubuque, Iowa, talked about her pharmacy’s offerings and how they serve her community’s patients.
Pharmacy Times
OCTOBER 16, 2024
Cardiovascular diseases have a significant impact on brain health and function.
Drug Topics
OCTOBER 16, 2024
David Pope, PharmD, Chief Pharmacy Officer at XiFin, further discussed value-based care and his company’s ongoing collaboration with pharmacies across the country.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
OCTOBER 16, 2024
Barney Graham, who for decades helped lead U.S. vaccine development efforts , said Wednesday that the lack of cooperation among U.S. agencies is hindering the country’s response to the H5N1 bird flu outbreak among dairy cattle, echoing criticisms that have been building over the past six months. “The USDA and the CDC and the NIH are not sharing and coordinating,” Graham said, referring to the federal agriculture department, the Centers for Disease Control and Preventio
Pharmacy Times
OCTOBER 16, 2024
The increase was observed across multiple subgroups, including those with overweight or obesity and hospitalized patients.
STAT
OCTOBER 16, 2024
They call it “failure to rescue,” which means a surgical patient died from complications that might have been averted if recognized and treated. New research suggests that’s why women are less likely to survive high-risk cardiovascular surgery than men. Female patients who underwent four common but serious procedures — abdominal aortic aneurysm repair, coronary artery bypass surgery, or atrial or mitral valve replacements — later developed complications a
Pharmacy Times
OCTOBER 16, 2024
The results indicate the potential use of loncastuximab tesirine as a treatment option for the rare hyperinflammatory condition.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
OCTOBER 16, 2024
If it weren’t for Martin Shkreli, better known as the Pharma Bro, Mark Cuban might not have gone into the drug business. That’s what he told me in this week’s episode of the “First Opinion Podcast.” He first started speaking with Alex Oshmyansky — the radiologist who would become his co-founder in Mark Cuban Cost Plus Drugs — around when Shkreli was heading to prison.
Pharmacy Times
OCTOBER 16, 2024
The updated recommendations include CGRP inhibitors as a first-line treatment option for chronic and episodic migraine prevention.
STAT
OCTOBER 16, 2024
Inspiration for a career in science can come from any number of sources. For Diane Shao , a neurogeneticist at Boston Children’s Hospital and general partner at Legacy Venture Capital, her mother motivated her to take the plunge into biotech. For Jorge Diego Martin-Rufino , a physician scientist at the Broad Institute and Boston Children’s Hospital, it was the pioneering geneticist Eric Lander, who advised him during his Ph.D.
pharmaphorum
OCTOBER 16, 2024
Pfizer partners with US biotech Triana Biomedicines in a deal focusing on molecular glue degraders that could be worth $1.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
OCTOBER 16, 2024
Robert Califf, a cardiologist and commissioner of the U.S. Food and Drug Administration, has been deeply involved in cardiovascular research: investigating health outcomes, health care quality, and clinical research in large, complex studies. In a recent conversation with STAT, though, he invoked his role as a grandfather, challenged in a grocery store checkout line to resist the ultra-processed foods marketed to American children and adults.
pharmaphorum
OCTOBER 16, 2024
NIH study finds Bavarian Nordic's mpox vaccine is effective in adolescents, a particularly vulnerable group amid the ongoing outbreak
STAT
OCTOBER 16, 2024
Onward Medical is betting big on neurostimulation as a tool to improve the quality of life for people with paralysis, said CEO Dave Marver. Bullish after recent clinical success, Marver spoke about the Swiss company’s future plans at the 2024 STAT Summit in Boston, including a device that can better regulate an underactive bladder.
pharmaphorum
OCTOBER 16, 2024
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens. The technology proved vital in aiding understanding of the evolution of and spread of virus in real time to inform public health measures, ultimately accelerating drug and vaccine development.
STAT
OCTOBER 16, 2024
Food and Drug Administration leaders are signaling new flexibility in the agency’s approach to evaluating new therapies to help people stop smoking. In a perspective paper published with the National Institutes of Health this week, the agency labeled the effort to help Americans quit smoking a top priority and said it was willing to consider broader endpoints in clinical trials of smoking cessation products.
Fierce Healthcare
OCTOBER 16, 2024
Medicare's annual enrollment period is officially underway, and, to assist beneficiaries in selecting plans, U.S. | Medicare's annual enrollment period is officially underway, and to assist beneficiaries in selecting plans, U.S. News & World Report has released its list of the best Medicare Advantage and Part D insurers.
STAT
OCTOBER 16, 2024
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! My editor said that the uncertainty in my write-up below on Helen’s story (“ Is it time to freak out about bird flu? “) reminded her of this iconic moment from NBC’s “30 Rock.
Pharmacy Times
OCTOBER 16, 2024
Artificial intelligence holds immense potential to address the rising demand for oncology services and improve patient outcomes by facilitating more effective, efficient, personalized cancer care.
STAT
OCTOBER 16, 2024
Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.
PharmaVoice
OCTOBER 16, 2024
Industry leaders charting new paths in science and business.
STAT
OCTOBER 16, 2024
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning. I’ve arrived in Boston for our annual STAT summit , and I successfully guilted my colleague Adam Feuerstein into baking me a cheesecake.
The Guardian - Pharmaceutical Industry
OCTOBER 16, 2024
More than 200 doctors and experts warn health secretary of ‘enormous pressure’ on already stretched services More than 200 doctors and medical experts have warned that the unprecedented demand for new obesity drugs is threatening to overwhelm the NHS. In a joint letter to the health secretary, Wes Streeting, the healthcare professionals call for an urgent review of services for millions of people struggling with weight.
Med Ed 101
OCTOBER 16, 2024
Pivmecillinam, also known as Pivya, is an oral antibiotic that was FDA-approved in April of 2024 for use against uncomplicated urinary tract infections (UTI) in female patients.1 Pivmecillinam Literature Pivmecillinam falls in the class of penicillin antibiotics. It is a prodrug that contains pivaloyloxymethylester of the amidinopenicillanic acid which is converted to mecillinam.
Pharmacy Times
OCTOBER 16, 2024
Pharmacogenomic testing can help identify patients' genetic profiles, revealing why certain drugs may be less effective or cause adverse effects.
pharmaphorum
OCTOBER 16, 2024
Discover effective strategies for commercialising oncology treatments for young adults with cancer, and learn how these targeted approaches can improve patient outcomes and access to innovative therapies.
Expert insights. Personalized for you.
524 
Let's personalize your content